Pharma Data Science

Johnson & Johnson’s Open Source Journey with R in Clinical Trials

Learn how Johnson & Johnson embraces R and open-source tooling in clinical trials.

Abstract: Embracing open source has been a transformative journey for J&J, fueled by a commitment to collaboration, transparency, and innovation. Our R journey began with a mindset shift—transitioning from decades-old solutions to actively contributing to and harnessing the power of open-source communities. We navigated the challenges of cultural adaptation while cultivating a programmer-friendly environment that promotes sharing and continuous learning.

We enhanced our technical capabilities by open-sourcing key projects focused on R and strengthened our ecosystem and industry partnerships. This webinar reflects on our experiences, lessons learned, and the strategic impact of embracing R.

Speakers: Sumesh Kalappurakal, Tadeusz Lewandowski, Nicholas Masel, and Mark Bynens.

Pharma Open-Source Packages and the R Validation Hub | A conversation with Aaron Clark

Posit’s Director of Life Sciences, Phil Bowsher, sat down with Aaron Clark, Senior Principal Clinical Scientist at Arcus Biosciences, to discuss various topics within the open-source clinical reporting space including Aaron’s career in pharma, the R Validation Hub, the open-source package riskmetric, and more.